Litigation Details for Astellas Pharma Inc. v. Zydus Pharmaceuticals (USA), Inc. (D. Del. 2016)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Zydus Pharmaceuticals (USA), Inc. (D. Del. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-10-11 |
| Court | District Court, D. Delaware | Date Terminated | 2019-09-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | Christopher J. Burke |
| Patents | 6,346,532; 7,342,117; 7,982,049; 8,835,474; RE44,872 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Astellas Pharma Inc. v. Zydus Pharmaceuticals (USA), Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Astellas Pharma Inc. v. Zydus Pharmaceuticals (USA), Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-01-16 | 18 | the ‘117 patent, the ‘049 patent, the ‘474 patent, the ‘872 patent and U.S. Patent No. 6,346,532 (“the …117 patent, the ‘049 patent, the ‘474 patent, the ‘872 patent and the ‘532 patent “cover[] the mirabegron…in the ‘117 patent, the ‘049 patent, the ‘474 patent, the ‘872 patent and the ‘532 patent and, therefore…valid claim of the ‘117 patent, the ‘049 patent, the ‘474 patent or the ‘872 patent. Defendants deny all…with respect to the ‘117 patent, the ‘049 patent, ‘474 patent and the ‘872 patent. Defendants deny all | External link to document | |
| 2019-09-13 | 26 | Order | States Patent Nos. 7,342,117, 7,982,049, 8,835,474, and RE44,872 (collectively “Patents-in-suit…related to the 7,342,117, 7,982,049, 8,835,474, and RE44,872 (collectively “Patents-in-suit”) in… 13 September 2019 1:16-cv-00924 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
